Pages that link to "Q46824829"
Jump to navigation
Jump to search
The following pages link to Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives (Q46824829):
Displaying 29 items.
- Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors (Q27324263) (← links)
- Identification of potent maturation inhibitors against HIV-1 clade C (Q28829072) (← links)
- Efficient synthesis and biological evaluation of epiceanothic acid and related compounds (Q34440864) (← links)
- HIV entry inhibitors and their potential in HIV therapy (Q34595921) (← links)
- The role of dynamin in HIV type 1 Env-mediated cell-cell fusion (Q35179370) (← links)
- Discovery of novel 5-fluoro-N(2),N(4)-diphenylpyrimidine-2,4-diamines as potent inhibitors against CDK2 and CDK9. (Q35524888) (← links)
- Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants (Q36185528) (← links)
- Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors. (Q36340098) (← links)
- Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors (Q36681723) (← links)
- Plant-derived natural product research aimed at new drug discovery (Q37143309) (← links)
- Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents (Q37173329) (← links)
- Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents (Q37330178) (← links)
- Dual-acting stapled peptides target both HIV-1 entry and assembly (Q37348096) (← links)
- Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors (Q37459163) (← links)
- A-ring modified betulinic acid derivatives as potent cancer preventive agents (Q37606087) (← links)
- Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach (Q37699332) (← links)
- Synthesis and anti-HCV entry activity studies of β-cyclodextrin-pentacyclic triterpene conjugates (Q39016028) (← links)
- Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1. (Q40063752) (← links)
- Activation and inhibition of the proteasome by betulinic acid and its derivatives (Q40074485) (← links)
- Betulinic Acid from Zizyphus Joazeiro Bark Using Focused Microwave-Assisted Extraction and Response Surface Methodology (Q40187447) (← links)
- An Amphiphilic Conjugate Approach toward the Design and Synthesis of Betulinic Acid–Polyphenol Conjugates as Inhibitors of the HIV‐1 gp41 Fusion Core Formation (Q42732016) (← links)
- Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors (Q47575865) (← links)
- Competitive affinity-based proteome profiling and imaging to reveal potential cellular targets of betulinic acid. (Q52936409) (← links)
- Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets. (Q53688749) (← links)
- Distribution and expression characteristics of triterpenoids and OSC genes in white birch (Betula platyphylla suk.) (Q54367043) (← links)
- Update on the development of HIV entry inhibitors (Q58388992) (← links)
- Structure and Anti-HIV Activity of Betulinic Acid Analogues (Q59355393) (← links)
- Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking (Q82072060) (← links)
- Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives (Q83878083) (← links)